Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Cancer Biomarkers by Profiling
5.1 Cytogenetics-Based Tests
5.1.1 Market Size and Forecast
5.2 Imaging Technologies
5.2.1 Market Size and Forecast
5.3 Immunoassays
5.3.1 Market Size and Forecast
5.4 Omic Technologies
5.4.1 Market Size and Forecast

Part 6. Global Market for Cancer Biomarkers by Cancer Type
6.1 Breast Cancer
6.1.1 Market Size and Forecast
6.2 Colorectal Cancer
6.2.1 Market Size and Forecast
6.3 Lung Cancer
6.3.1 Market Size and Forecast
6.4 Prostate Cancer
6.4.1 Market Size and Forecast
6.5 Stomach Cancer
6.5.1 Market Size and Forecast
6.6 Others
6.6.1 Market Size and Forecast

Part 7. Global Market for Cancer Biomarkers by Application
7.1 Diagnostics
7.1.1 Market Size and Forecast
7.2 Drug Discovery & Development
7.2.1 Market Size and Forecast
7.3 Prognostics
7.3.1 Market Size and Forecast
7.4 Risk Assessment
7.4.1 Market Size and Forecast
7.5 Others
7.5.1 Market Size and Forecast

Part 8. Global Market for Cancer Biomarkers by Region
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles
9.1 Abbott Laboratories
9.2 Bio-rad laboratories, Inc.
9.3 Bristol-Myers Squibb (BMS) Company
9.4 EXACT Sciences Corporation
9.5 Merck KGaA
9.6 PerkinElmer, inc.
9.7 Qiagen N.V.
9.8 Roche Holding AG
9.9 Siemens AG
9.10 Thermo Fisher Scientific, Inc.
*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY